Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients

Table 1

Patients’ characteristics.

Feature	Mean	Range
Age (years)	69,	55–81
Weight (Kg)	72,,6	44–111
PSA (ng/ml)		3–9375
Gleason score		5–9
Disease duration (months)	90,	13,7–275,8
Skeletal metastases duration (months)	36,	1,1–139,8
CRPC duration (months)		1,9–105
Previous docetaxel	34 (72%)	-
Previous skeletal RT	12 (26%)	-
Focal lesions at SPECT MIP		34–135
Mean baseline hemoglobin		8,8–16,2
Mean baseline leucocytes		3100–10940
Mean baseline platelets		71–351